61 Kazia Theraputics Limited Annual Report 2022 2022 at a Glance Chairman’s Letter CEO’s Report Key Milestones Pipeline Review ESG Financial Reports Note 16. Contingent consideration continued Contingent consideration - EVT801 As set out in note 2, the acquisition of EVT801 has been accounted at cost as a separately acquired intangible asset with milestones where the payment is considered probable being booked as a current or non-current liability at year end, according to the estimated payment date. Milestones where the payment is not considered probable at year end have not been accounted for as a liability. The total amount of milestone payments not booked at year end amounts to €300,500,000 ($456,063,136). Note 17. Deferred tax Consolidated 2022 2021 $ $ Non-current liabilities Deferred tax liability associated with Licensing Agreement 2,560,361 2,928,441 Company management has completed an analysis of the availability of historical tax losses to offset the deferred tax liability. Accordingly, the company concludes that the historical tax losses are not expected to be available for offset against the deferred tax liability. Note 18. Contributed equity Consolidated 2022 2021 2022 2021 Shares Shares $ $ Ordinary shares – fully paid 138,755,376 132,012,209 84,480,249 80,290,062 Movements in ordinary share capital Details Date Shares Issue price $ Balance 1 July 2020 94,598,369 48,781,214 Issued on conversion of options 28 August 2020 25,000 $0.4930 12,313 Institutional placement under ANREO 12 October 2020 20,525,820 $0.8000 16,420,656 Retail placement under ANREO 26 October 2020 11,017,075 $0.8000 8,813,660 Issued on conversion of options 2 March 2021 391,500 $0.6350 248,661 Issued on conversion of options 15 March 2021 25,000 $0.4930 12,313 Share placement 28 April 2021 3,037,580 $1.4070 4,274,633 Issued on achievement of milestone 21 May 2021 2,391,865 $1.4210 3,400,000 Less: share issue transaction costs - $0.0000 (1,673,388) Balance 30 June 2021 132,012,209 80,290,062 Issued on conversion of options 15 December 2021 25,000 $0.6680 16,700 Conversion of Triaxial Convertible Note 5 May 2022 1,855,357 $0.2500 464,000 ATM issue of shares No. 1 24 May 2022 10,000 $0.8260 8,256 ATM issue of shares No. 2 2 June 2022 10,000 $0.8020 8,025 ATM issue of shares No. 3 6 June 2022 88,710 $0.8370 74,258 ATM issue of shares No. 4 9 June 2022 603,500 $0.8400 507,035 ATM issue of shares No. 5 14 June 2022 75,940 $0.8240 62,583 ATM issue of shares No. 6 15 June 2022 2,000 $0.8300 1,661 ATM issue of shares No. 7 20 June 2022 4,072,660 $0.8690 3,540,403 Less: share issue transaction costs - $0.0000 (492,734) Balance 30 June 2022 138,755,376 84,480,249 Our Collaborators
RkJQdWJsaXNoZXIy MjE2NDg3